This contract expires in 166 days (Sep 30, 2026).
FIRM FIXED PRICE
EXELAN PHARMACEUTICALS INC - VA PALO ALTO LENALIDOMIDE ORAL CAPSULES
PIID: 36C26126N0175
Signed Date: Oct 20, 2025Effective Date: Oct 17, 2025End Date: Closes in 166 days
Key Details
Description
VA PALO ALTO LENALIDOMIDE ORAL CAPSULES
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.